Your browser doesn't support javascript.
loading
Safety and efficacy of pegylated liposomal doxorubicin-based adjuvant chemotherapy in patients with stage I-III triple-negative breast cancer.
Lien, Ming-Yu; Liu, Liang-Chih; Wang, Hwei-Chung; Yeh, Ming-Hsin; Chen, Chih-Jung; Yeh, Su-Peng; Bai, Li-Yuan; Liao, Yu-Min; Lin, Chen-Yuan; Hsieh, Ching-Yun; Lin, Ching-Chan; Li, Long-Yuan; Lin, Po-Han; Chiu, Chang-Fang.
Afiliação
  • Lien MY; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Liu LC; Department of Surgery, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Wang HC; Department of Surgery, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Yeh MH; Department of Surgery, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Chen CJ; Department of Surgery, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Yeh SP; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, R.O.C. Internal Medicine, College of Medicine, China Medical University, Taichung, Taiwan, R.O.C.
  • Bai LY; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, R.O.C. Internal Medicine, College of Medicine, China Medical University, Taichung, Taiwan, R.O.C.
  • Liao YM; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Lin CY; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Hsieh CY; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, R.O.C. Graduate Institute of Clinical Medicine, China Medical University, Taichung, Taiwan, R.O.C.
  • Lin CC; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, R.O.C. Graduate Institute of Clinical Medicine, China Medical University, Taichung, Taiwan, R.O.C.
  • Li LY; Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan, R.O.C.
  • Lin PH; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, R.O.C. Department of Medical Genetics, China Medical University Hospital, Taichung, Taiwan, R.O.C. Internal Medicine, College of Medicine, China Medical University, Taichung, Ta
  • Chiu CF; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, R.O.C. Internal Medicine, College of Medicine, China Medical University, Taichung, Taiwan, R.O.C. pohanlin01@gmail.com cftl00@gmail.com.
Anticancer Res ; 34(12): 7319-26, 2014 Dec.
Article em En | MEDLINE | ID: mdl-25503167
Assuntos
Palavras-chave
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Doxorrubicina / Neoplasias de Mama Triplo Negativas / Antibióticos Antineoplásicos Limite: Female / Humans / Middle aged Idioma: En Revista: Anticancer Res Ano de publicação: 2014 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Doxorrubicina / Neoplasias de Mama Triplo Negativas / Antibióticos Antineoplásicos Limite: Female / Humans / Middle aged Idioma: En Revista: Anticancer Res Ano de publicação: 2014 Tipo de documento: Article